– Persephone to utilize the Bacteroides technology for the rapid generation of therapeutics from its planned and ongoing biomarker studies, including the ARGONAUT study – Ginkgo retains the rights to leverage the toolkit to address a wide range of customer needs and applications SAN DIEGO…